420 with CNW — An Overview of Cannabis Legislation Approved Last Week Across the US

The past week has been quite a busy time for cannabis reform. Lawmakers recently tabled a bill seeking to legalize cannabis at the federal level, while legislators from four states approved new marijuana legalization bills in various committees. In the wake of last year’s slew of cannabis reform victories at the state level, legislators have been keen on cannabis legalization, whether by leveraging the momentum of the state-level legislation or by getting ahead of campaigners to craft their own cannabis legislation rather than wait for policy change through the ballot.

In Hawaii, the Senate Committee responsible for Intergovernmental, Public Safety and Military Affairs gave the nod to two bills that would legalize cannabis and increase the allowed limit. Bill SB-767 aims to legalize marijuana for adults aged at least 21 years, as well as allow state-licensed businesses to grow, produce and sell cannabis products. Adults aged 21 and over would also be able to grow a maximum of three mature plants for their personal consumption. Bill SB 758 would increase the threshold one can possess from 5 grams of cannabis to 28.5 grams (one ounce).

Minnesota’s House Committee in charge of Commerce and Finance Policy approved a bill to legalize cannabis. Filed this month by Majority Leader of the House Ryan Winkler and joined by other legislators, the bill seeks to allow adults who are at 21 years old to buy and possess a maximum of 1.5 ounces of marijuana as well as grow up to eight cannabis plants, including four mature ones.

In New Mexico, the House committee in charge of Health and Human Services passed a proposed measure to legalize cannabis through a 7–4 lawmaker vote. The measure plans to allow adults aged at least 21 to possess two ounces of marijuana and cultivate a maximum of six immature plants as well as six mature plants for their own personal consumption. It also seeks to create a mechanism to regulate and tax cannabis sales, with the tax revenue being used to reinvest in communities that were impacted the most by the drug war.

A North Dakota committee narrowly passed a Republican-sponsored measure that would legalize recreational marijuana use by adults. The Human Service House committee passed the bill, which plans to allow adults who are at least 21 years or more to have cannabis and buy up to an ounce for their personal use, through a close 7–6 narrow win. The bill is now expected to head to the Appropriations Committee before being considered on the floor.

Other states that saw drug reform action include California, where a number of lawmakers tabled a bill to legalize psychedelics possession; New Jersey, which passed a bill that would clear the way for implementing the state’s voter-supported cannabis legislation; Virginia, where both Houses of the legislature voted to legalize cannabis; Washington State, where a committee passed a bill to decriminalize personal use of small quantities of all currently illegal drugs; and Wisconsin, which published a budgetary proposal calling for the legalization of both therapeutic and recreational use of cannabis.

Business is thriving in states that already have legal cannabis markets. For example, Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) is licensed in Nevada and Oregon in addition to having distribution partnerships in California. These operations have seen the company recruit a total of at least 160 permanent employees to serve its growing client base.

NOTE TO INVESTORS: The latest news and updates relating to Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) are available in the company’s newsroom at https://cnw.fm/GLDFF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — CBD Added to EU Database of Accepted Cosmetic Ingredients

Although cannabidiol (“CBD”) has enjoyed immense popularity in the past couple of years, the hemp extract is still barely regulated in most territories. In the United States, different states have different CBD regulations, and the situation isn’t any different in Europe. However, the European Union has moved a step closer towards standard legislation after CBD was added as a cosmetic ingredient in the EU’s database.

The EU’s Directorate-General for Internal Market, Industry, Entrepreneurship, and SMEs added CBD to its CosIng guidelines as a cosmetic ingredient. This revision to the guidelines comes after the Court of Justice of the European Union (“CJEU”) ruled that under the UN Single Convention on Narcotic Drugs of 1961, cannabidiol extracted from the hemp plant in its entirety is not a narcotic. Consequently, the court ruled that CBD should be traded between the Union’s member states freely.

Before the revision, only synthetic CBD was allowed as a cosmetic ingredient. The CosIng guidelines are a database of cosmetic regulations that identify legal and illegal ingredients and define their functions and benefits. Now that CBD derived from the hemp plant has been added to the list, it can be used as a cosmetic ingredient as an anti-sebum, skin protectant, skin conditioner and antioxidant.

At the moment, CBD regulations differ wildly among member states, leading to a patchwork of regulation across the EU. For instance, some countries allow up to 1% THC in CBD cosmetic products while others are more punitive and do not allow any THC. On top of that, different countries also have different requirements for manufacturing, labeling and marketing CBD cosmetic products. This patchwork of regulations forces manufacturers and distributors to adhere to different rules and regulations in each country in which they transact, essentially preventing these companies from trading their goods freely within the European Union.

The CosIng guidelines may not be legally binding, but they serve as a guide for EU member states when they craft their own cosmetic product regulations. The guidelines aim to bolster the creation of standardized CBD regulations across the EU to allow free movement of CBD cosmetics. The revision is a small but definite step towards achieving a standard regulatory framework for CBD in the European Union. What is definitely legally binding on all member states, however, is the CJEU ruling that came out before the revision to the regulations.

Due to the historic ruling, all European governments that were keeping companies from marketing and selling CBD cosmetics will have to amend the cannabidiol regulations.

Still on the subject of CBD, lots of exciting innovations are happening in this space. An example is Grapefruit USA Inc. (OTCQB: GPFT). Grapefruit harnesses advanced science and technology to bring patented products to the cannabis marketplace. The company is revolutionizing the way people use THC, CBDs and hemp-derived CBDs while also capitalizing on the surging demand for these unique products.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — The Reddit Effect Takes Marijuana Stocks to a New High

Marijuana stocks are the latest stocks to experience the brief high driven by exposure on Reddit. This year, social media has demonstrated that it can be a powerful driver of retail, which has left analysts and investors wondering which company may be the next GameStop (NYSE: GME)

According to data provided by Quiver Quantitative, three of the five most-discussed companies on the r/WallStreetBets group on Reddit last week were marijuana stocks, which would explain why the focus moved to marijuana stocks.

According to Vanda Research, money followed shortly after, with retail investors pouring in ore than $440 million into marijuana stocks since February began. This figure was double the amount that had been invested in January.

This hefty investment sent prices soaring — before they dropped again. Tilray, a Canadian marijuana producer listed in the United States, began the week at $25 per share before quickly rising to $67 on Wednesday then declining significantly back to $29 by market close on Friday. Tilray was the second most traded share on Thursday on Robinhood, which is a trading platform.

This isn’t the first time the company has been the subject of attention from retail investors. After its IPO launch in 2018, the company’s stock price briefly spiraled to $300 per share due to a short squeeze.

Another Canadian marijuana producer, Sundial, was also among the companies with the most traded stocks on Robinhood. The company’s stock price increased to more than $1 on Monday before growing to $4 on Thursday. By Friday, the share price has dropped back to $2.

Vanda Research senior strategist Viraj Patel explained that when some company names begin gaining traction on StockTwits, Twitter and Reddit’s r/WallStreetBets, the hype is developed, which then brings about a network effect. This is when the money starts flowing, and the price starts to shift. Patel further explained that this herd behavior was unusual in the way that investors moved from one asset category to another swiftly.

Marijuana bulls point to the favorable paths of American policy. Flows into marijuana stocks have increased significantly since the November 2020 U.S. elections, when legalization was approved in many states across the country. The day after the election, the top five shares traded on Robinhood were all CBD firms.

According to data provider TrackInsight, assets under management by marijuana-tracking ETFs are at record highs of $1.9 billion, with $527 million flows in January — triple the previous record, which was set in 2020 December.

Cannabis companies, and especially those operating within the hemp space, are uniquely positioned for massive growth in the near future. Green Hygienics Holdings Inc. (OTCQB: GRYN) best exemplifies this, as the company has a balance sheet that is devoid of any overhang or toxic debt. This financial health allows GRYN to focus on developing new technologies to produce different pharmaceutical-grade hemp compounds.

NOTE TO INVESTORS: The latest news and updates relating to Green Hygienics Holdings Inc. (OTCQB: GRYN) are available in the company’s newsroom at http://cnw.fm/GRYN

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Marks Major Milestone Through Lords of Grasstown Acquisition

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”) today announced the closing of a share purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd., a company existing under the laws of British Columbia (“Grasstown”). Under the agreement, the company will acquire all issued and outstanding shares of Grasstown, a well-established cannabis motorcycle lifestyle brand with a tremendous following and acumen that spawned from the vision of Tyler Hazelwood, founder and director of Lords of Gastown. “This acquisition marks a major milestone for the company with a move into the U.S. Cannabis Market, predominantly in California, with the Grasstown Brand,” said Patrick Elliott, CEO of PacRoots. “The team at Lords of Grasstown has done a remarkable job branding, designing, launching and marketing Grasstown in BC and California. The alliances are real and the followers like what they see. We are thrilled to develop and expand Grasstown from Prince Rupert to San Diego. Tom and Tyler are authentic artists with a strong pedigree to prove it. We are inspired to have them as part of the team.”

To view the full press release, visit https://cnw.fm/tacRw

About Pac Roots Cannabis Corp.

Pac Roots is the future of genetics. By focusing on elite cannabis genetic development, the company maximizes the quality of its products, by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners; Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars as well as its JV partnership with Rock Creek Farms and Speakeasy Cannabis Club, leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within their first year of trading. For more information about the company, visit www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots are available in the company’s newsroom at http://cnw.fm/PACR

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Obtains California Trademark Protection for Flagship Hourglass Cream

Grapefruit USA (OTCQB:GPFT), a premiere, fully licensed California-based cannabis company, announced that it has secured trademark protection for its Hourglass name and logo. The now-protected name and logo are used on Grapefruit’s patented disruptive Hourglass(TM) THC/cannabinoid time-release delivery cream. With the approved trademark, the Hourglass name and logo are now categorized as protected intellectual property rights of Grapefruit USA Inc. That status means that no other company operating in the cannabis space can use the property; the announcement noted that Grapefruit also possesses common-law, first-in-time, trademark protection to Hourglass. In addition, the company has secured California trademark and service mark protections for the Grapefruit corporate name and other product lines including Sugar Stoned and Rainbow Dreams. The company intends to obtain federal trademark protection when the federal government legalizes cannabis. “Obtaining our California trademark protection for Hourglass is pivotal for us to protect our intellectual property rights and goodwill with respect to Grapefruit’s Hourglass line of products,” said Grapefruit CEO Bradley J. Yourist in the press release. “It is only fitting that Grapefruit has exclusive rights to the Hourglass name and logo since Grapefruit has an exclusive license for use of the patented technology upon which the Hourglass time release delivery cream is based and is the only enterprise on earth with the technical know-how to manufacture the Hourglass delivery cream for the regulated cannabis market. That symmetry is exquisite. Securing our trade name is another step forward in the dawning of the Hourglass Era. Hourglass products may only be obtained from Grapefruit and its authorized agents.”

To view the full press release, visit https://cnw.fm/Nnb0Y

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Medical Marijuana Shares Off to a Great Start on London Stock Exchange

Marijuana shares in the UK have been rising quickly, with investors now looking toward a new investment class in the market: medical marijuana shares.

Last week, MGC Pharma, which is London’s first marijuana stock, debuted on the London Stock Exchange. The firm raised £6.5 million ($9 million) on its premiere, with the stock moving to 4.25p (59 cents) a share from a 1.475p (25 cents) per share opening price. This left the company with a market cap of more than £75 million ($104 million).

In a way, the increase in the London stock mirrored the American market, when investors from Reddit’s r/WallStreetBets forced the price of various marijuana stocks to rise on the back of an Aphria and Tilray merger. The likelihood of President Joe Biden’s administration federally legalizing the marijuana industry has also helped.

Tilray Inc. (NASDAQ: TLRY) rose by 50%, which added more than $2 billion in value to the company’s stock. This upped the company’s yearly gains to more than 670%. Other companies that have recorded significant gains this year are Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), which has increased by more than 120% so far; Aphria Inc. (NASDAQ: APHA), which was up by 280%; and Canopy Growth Corp. (TSX: WEED) (NYSE: CGC), which rose by 110%.

So far, London has been slow to launch medical marijuana IPOs. However, following MGC Pharma’s remarkable reception last week after a two-year campaign by Memery Crystal, a London law firm, attitudes may at last be changing.

Up until now, regulators and banks were concerned that marijuana businesses would be seen as almost-criminal enterprises; turns out, this may not be the case. Memery Crystal CEO, Nick Davis, who is also an advocate campaigning for the medicinal use of marijuana, stated that after MGC Pharma’s successful IPO, he received calls from America, Canada and Israel, all from companies that wanted to list in the United Kingdom.

Over in the United States, medical marijuana is legal in 30 states. Projections from Prohibition Partners show that by 2024, the country’s market will be valued at $37.9 billion. The firm also estimates that by 2024, nearly 340,000 patients in the UK will be using marijuana treatments. Additionally, their research states that by 2024, UK’s legal marijuana market will be valued at nearly £2.3 billion.

In the UK, research focused on the medical applications of marijuana is still in the early stages. Many are hopeful, however, that London may soon become the right place for the growing marijuana market to raise funds to finance further medical studies and research. However, advocates are still emphasizing that the whole point of this is not to help individuals get high but to help manage pain and relieve human suffering.

Furthermore, guidelines from the National Institute for Health Care and Excellence asserted that the medication from MGC Pharma was effective, which assisted in moving things along.

Back in the States, Gage Growth Corp. (d.b.a. Gage Cannabis) , which operates within the Michigan marijuana market, has initiated a number of steps intended to grow its brand. For example, the compamy has exclusive brand partnerships with some of the most recognizable brands, such as Cookies, across the country. Such partnerships are likely to see the company grow more rapidly than its competitors.

NOTE TO INVESTORS: The latest news and updates relating to Gage Growth Corp. (d.b.a. Gage Cannabis) are available in the company’s newsroom at https://cnw.fm/GAGE

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Why Cannabis Concentrate Sales Are Booming

Despite a pandemic ravaging the global economy last year, the cannabis industry survived relatively unscathed. In most states where legal marijuana markets categorized the controversial crop as essential, cannabis sellers were allowed to continue their operations amid lockdown orders. But while cannabis flower enjoyed consistently high sales numbers, cannabis concentrates were also carving out a market for themselves.

Comparing sales data collected from January to November 2020 to data collected over the same period the year before, data analytics firm Headset found that there was a 40% surge in marijuana concentrate sales in states such as Colorado, Nevada, California and Washington. Oregon’s recreational and medical marijuana markets registered the same increase in sales. According to the Seattle-based firm, total cannabis concentrate sales increased to $797 million in 2020 from $567 million in 2019. The boom in cannabis concentrate sales can be attributed to the following:

Maturing consumption. Marijuana users usually start with cannabis flower and, as they get more experienced, work their way up to the more potent stuff. President and CEO of Ammonite Mike McDonald says heavy users consume cannabis every day, building up a tolerance over time. The San Francisco Bay Area-based firm has seen concentrates become popular in more mature markets such as California and Colorado, McDonald says. Since concentrates contain up to 90% THC, people usually start using them as they grow more experienced.

Technological advancements. Consuming a concentrate isn’t as simple as smoking cannabis flower or dining on an edible. It requires a complicated smoking tool known as a dab rig, a major reason why many users wait until they are more experienced to give concentrates a try. But with the development of new portable technology such as handheld vaporizers, more customers can use concentrates. Small, portable, battery-powered vaporizers have pushed the trend, says McDonald, allowing customers to carry the vaporizer along with a one-gram jar of concentrate discreetly and with ease.

An alternative to vaping. Vape pens were all the rage when they first came out. However, after the vaping health crisis in 2019 left more than 2,500 people hospitalized with cases of lung illness, most users became extremely careful about what they consumed and how they consumed it. Gone were the solvents and common additives as people started turning to solventless extracts such as live resin and rosin. Katie Bacjar, director of marketing at Spherex, a cannabis extraction company based in Aurora, Colorado, says people are moving towards cleaner cannabis oils and other products.

Although solventless products are difficult to scale up, she says that they are steadily reducing the fear of vaping.

Speaking of cannabis concentrates, Canada-based Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) has distinguished itself in that market as the leader in extracting cannabis compounds, a rapidly growing segment of the industry.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Benzinga Cannabis Capital Conference to Showcase Industry Innovators, Latest Trends

The Benzinga Cannabis Capital Conference, known as the premier gathering of cannabis entrepreneurs and investors in North America, will return for its tenth installment in an entirely digital format on Feb. 25-26, 2021. The event brings together some of the industry’s leading cannabis companies to shine the spotlight on their latest developments and meet with existing and potential investors. The forum features a series of enlightening keynote addresses and a succession of one-on-one meetings designed to bring financiers in contact with some of the sector’s most exciting and innovative corporations. This year’s event will host a series of live presentations from more than 30 cannabis companies alongside a number of exclusive industry panels, interviews with executives and more. In addition, CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company, was again re-engaged to serve as the Benzinga Cannabis Capital Conference’s Official NewsWire. In addition to disseminating press releases, CNW will be working alongside the InvestorBrandNetwork (“IBN”) to provide each of the attending publicly traded companies with dedicated virtual coverage, including amplified article syndication to 5,000+ strategic syndication partners and publication of the event through multiple investor-oriented newsletters. “Our team is excited to be working alongside Benzinga’s event organizers once again,” said CNW Director of Communications Jonathan Keim. “This well-experienced organization is known throughout the space for consistently attracting North America’s leading cannabis innovators, investors and entrepreneurs.”

To view the full press release, visit https://cnw.fm/Lw9Wj

About Benzinga

Benzinga is a leading financial media company dedicated to making information easier to consume. Benzinga’s news desk is constantly breaking stories and moving billions of dollars of market capitalization through its real-time news tool, Benzinga Pro. Benzinga’s original content is syndicated to 70 partner websites including Yahoo! Finance MSN, CNNMoney, Fox Business and MarketWatch. For more information, or to register for the Virtual Cannabis Capital Conference, visit www.Benzinga.com.

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — Goldleaf Guided Journals: The Best for At-Home Marijuana Growers

If you have an obsession with buying notebooks, or just like them generally, and you also like and grow your own medical cannabis, then a Goldleaf guided journal may be perfect for you.

A Goldleaf guided journal is a minimalist notebook for marijuana home-growers as well asrecreational and medical users of the plant. Each journal comes with industry and medical advice supported by experts, ideal information for individuals who may be looking to deepen their understanding about the medicinal plant.

In particular, the grow planner adheres to marijuana farmers’ tradition of taking comprehensive notes to help compare the failures and successes of grows with time. This planner comes in a Moleskine-esque stylish design that has been tailored to suit the needs of intermediate and beginner marijuana home growers.

Charles McElroy, the founder of the company that makes Goldleaf planners, explained that the grow planner was suitable for individuals who would like to learn more about their craft. He added that Goldleaf’s intended customers were growers who were similar to him, describing himself as a self-confessed perfectionist who would like to learn from past errors and improve upon those mistakes.

This means that the journal wouldn’t be suitable for first-time marijuana growers or total beginners. However, beginners who would still like to use the Goldleaf Journal would have to conduct research on various soil-less growing methods as well as the basics of soil, light, nutrients and pH controls before they started growing.

Despite this, however, the grow journals are useful in helping growers keep track of their progress, if they have already made a decision on the different methods they’ll be using.

The grow journal comes in two types: the longer grow journal and the smaller grow jotter. While the latter is made up of two-page spreads for users to help track their plants’ nutrient regimens, a section for tracking cultivar particulars and templated day-to-day entry pages, the former is made up of these features, in addition to pages for tasting notes, a chart for plotting a plant’s health and month-to-month and yearly calendars.

Furthermore, when either journal is purchased, the owner receives a set of grower reference cards that contain tips on various things, such as how to diagnose a plant’s health issues or how to calculate how much energy is being used.

McElroy also explained that the idea behind Goldleaf was to find a way to show the science behind marijuana in a way that was more mature and digestible.

People who are growing their own medical cannabis may be glad to know that XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is set to conduct trials for a number of its cannabinoid-based treatments for spasticity linked to MS, Parkinson’s disease and other conditions.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Appeals Court Rules That Probationers in Michigan Can Use Medical Cannabis

In June 2019, 39-year-old Michael Thue was involved in a road rage incident, ultimately pleading guilty to assault and battery. Thue, who is a state-registered medical cannabis patient, was given a year of probation as part of his sentence and ordered not to use medical marijuana during the year of probation. He fought the bond condition, lost and took the case to the Court of Appeals, resulting in a historic and precedent-setting ruling by the court.

The Court of Appeal judges unanimously ruled in a 3–0 vote that Michigan judges could not prevent state-registered medical marijuana patients from using medical cannabis during probation. Issued by Court of Appeals Judges Deborah A. Servitto, Mark. J. Kavanaugh and Thomas C. Cameron in writing, the ruling declared that the Medical Marijuana Act, passed by voters back in 2008, “preempts or supersedes” contradicting statutes and ordinances that allow judges to limit a variety of legal activities, including alcohol consumption.

Michael Komorm, the Farmington Hills-based defense lawyer who represented Thue in his appeal, said that while arguing the medical cannabis probation condition in a lower court, the opposing lawyer claimed that allowing a probationer to use medical cannabis was akin to letting someone on probation for drunk driving have a drink. However, he counters, there is no medical alcohol law. On the other hand, specific language in Michigan’s medical marijuana law prohibits state-registered patients from being penalized from using medical cannabis, he says.

In spite of this provision in the voter-passed legislation, judges, especially those in Grand Traverse County where Thue’s incident occurred, have been imposing medical cannabis restrictions on state-registered patients on probation. Komorm believes that now that the Court of Appeals has ruled that judges can no longer impose such restrictions, the precedent should apply to other parolees or defendants currently on bond who have been prohibited from using medical marijuana.

According to Grand Traverse County Prosecutor Noelle Moeggernberg, the Legislature will need to make a couple of changes for the precedent-setting ruling by the Court of Appeals to apply to individuals who are free on bond or parolees. Although she called the final ruling “problematic,” she revealed that there are currently no plans to appeal as the court’s reasoning is “sound.” Unfortunately for Thue, his probation ended in December, and the ruling won’t affect him.

The court cautioned that recreational use of marijuana, approved by voters in 2018, is not immune from marijuana prohibitions during probation.

Still on the subject of medical marijuana, RYAH Group Inc. has an exciting portfolio of IoT-based products, each of which is composed of a mobile application, a device and a component that carries the cannabis medication. These products bring precision to the administration of cannabis medicines.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.